IL-11

IL-11 Overview

English NameInterleukin-11Approved Drugs1
Drugs in Clinical Trials4Target SynonymOprelvekin,IL-11,Interleukin 11,Adipogenesis inhibitory factor,AGIF
Highest Development StageApproved
English NameInterleukin-11
Target SynonymOprelvekin,IL-11,Interleukin 11,Adipogenesis inhibitory factor,AGIF
Approved Drugs1
Drugs in Clinical Trials4
Highest Development StageApproved

IL-11 Product List

  • Product Category

    Protein (11)Kits (2)

  • Product Status

    Launched (13)

  • Species

    Human (6)Cynomolgus (3)Mouse (3)Canine (1)

  • Tag

    His Tag (5)His Tag & Avi Tag (4)Fc Tag (2)- (2)

  • Conjugate

    Unconjugated (7)Biotin-labeled (4)- (2)

IL-11 Background

Interleukin-11 (IL-11) is a pleiotropic cytokine that stimulates megakaryocytopoiesis, resulting in increased production of platelets, as well as activating osteoclasts, inhibiting epithelial cell proliferation and apoptosis, and inhibiting macrophage mediator production. These functions may be particularly important in mediating the hematopoietic, osseous and mucosal protective effects of IL-11. The cytokine also possesses anti-inflammatory activity, and has been proposed as a therapeutic agent in the treatment of chronic inflammatory diseases, such as Crohn's disease and rheumatoid arthritis. Although IL-11 was initially believed to be restricted to mammals, subsequent studies demonstrated it to be expressed in fish. Despite close similarity in gene structure and conservation of key amino acids between fish and mammalian IL-11, they share relatively low overall amino acid identity and may not necessarily be functionally analogous.

IL-11 Synonyms

IL-11,Interleukin-11,AGIF,Oprelvekin,IL11

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
9MW38119MW3811Phase 2 ClinicalMabwell (Shanghai) Bioscience Co LtdCicatrix; Fibrosis; Idiopathic Pulmonary Fibrosis; Neoplasms; Pulmonary Fibrosis; Solid tumours
Details
BI-765423BI-765423; BI765423Phase 2 ClinicalBoehringer Ingelheim LtdIdiopathic Pulmonary Fibrosis
Details
HB-0056HB-0056; HB0056Phase 1 ClinicalShanghai Huaota Biopharmaceutical Co Ltd, Zhejiang Huahai Pharmaceutical Co LtdAsthma; Dermatitis, Atopic; Idiopathic Pulmonary Fibrosis; Pulmonary Disease, Chronic Obstructive
Details
LASN-03Lassen Therapeutics
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
Recombinant human interleukin-11 (Hangzhou Jiuyuan Gene Engineering Co Ltd )ApprovedHangzhou Jiuyuan Gene Biomedical Co LtdThrombocytopenia
Details
  • Overview
  • Product List
  • Marketed Drug Information
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland